Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice.

Park HK, Qatanani M, Briggs ER, Ahima RS, Lazar MA.

Diabetes. 2011 Mar;60(3):775-83. doi: 10.2337/db10-1416. Epub 2011 Jan 31.

2.

Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.

Schwartz DR, Briggs ER, Qatanani M, Sawaya H, Sebag IA, Picard MH, Scherrer-Crosbie M, Lazar MA.

Endocrinology. 2013 Nov;154(11):4206-14. doi: 10.1210/en.2013-1399. Epub 2013 Aug 27.

3.

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA.

J Clin Invest. 2009 Mar;119(3):531-9. doi: 10.1172/JCI37273. Epub 2009 Feb 2.

4.

Autocrine effects of transgenic resistin reduce palmitate and glucose oxidation in brown adipose tissue.

Pravenec M, Mlejnek P, Zídek V, Landa V, Šimáková M, Šilhavý J, Strnad H, Eigner S, Eigner Henke K, Škop V, Malínská H, Trnovská J, Kazdová L, Drahota Z, Mráček T, Houštěk J.

Physiol Genomics. 2016 Jun;48(6):420-7. doi: 10.1152/physiolgenomics.00122.2015. Epub 2016 Apr 25.

5.
6.

An inflammatory cascade leading to hyperresistinemia in humans.

Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA.

PLoS Med. 2004 Nov;1(2):e45. Epub 2004 Nov 30. Review.

7.

Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients.

El-Shal AS, Pasha HF, Rashad NM.

Gene. 2013 Feb 15;515(1):233-8. doi: 10.1016/j.gene.2012.09.136. Epub 2012 Nov 20.

PMID:
23178185
8.
9.

Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.

PMID:
16740970
10.

Effect of endothelium-specific insulin resistance on endothelial function in vivo.

Duncan ER, Crossey PA, Walker S, Anilkumar N, Poston L, Douglas G, Ezzat VA, Wheatcroft SB, Shah AM, Kearney MT.

Diabetes. 2008 Dec;57(12):3307-14. doi: 10.2337/db07-1111. Epub 2008 Oct 3. Erratum in: Diabetes. 2009 Feb;58(2):511. Kearney, Mark I [correct to Kearney, Mark T].

11.

Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.

Huang X, Yang Z.

J Endocrinol Invest. 2016 Jun;39(6):607-15. doi: 10.1007/s40618-015-0408-2. Epub 2015 Dec 12. Review.

PMID:
26662574
12.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

13.

Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.

Dallaire P, Bellmann K, Laplante M, Gélinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A.

Diabetes. 2008 Aug;57(8):1999-2011. doi: 10.2337/db08-0540. Epub 2008 May 5.

14.

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.

Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P.

Kidney Int. 2006 Feb;69(3):596-604.

15.
16.

Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.

Carvalho E, Kotani K, Peroni OD, Kahn BB.

Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E551-61. Epub 2005 May 31.

17.

Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.

Makkonen J, Westerbacka J, Kolak M, Sutinen J, Cornér A, Hamsten A, Fisher RM, Yki-Järvinen H.

Int J Obes (Lond). 2007 Oct;31(10):1617-25. Epub 2007 Apr 24.

PMID:
17452990
18.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

19.

Metabolic endotoxemia initiates obesity and insulin resistance.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.

Diabetes. 2007 Jul;56(7):1761-72. Epub 2007 Apr 24.

20.

Resistin.

McTernan PG, Kusminski CM, Kumar S.

Curr Opin Lipidol. 2006 Apr;17(2):170-5. Review.

PMID:
16531754

Supplemental Content

Support Center